prednisone has been researched along with Hepatitis B, Chronic in 30 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Excerpt | Relevance | Reference |
---|---|---|
" We evaluated the safety and efficacy of lamivudine and interferon alfa-2b with prior immunosuppression with prednisone in patients with HBeAg-positive chronic hepatitis B (CHB)." | 9.12 | [Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B]. ( Arús Soler, E; Dávila González, Y; Grá Oramas, B; Ruenes Domech, C; Vilar Gómez, E, 2006) |
"This prospective study aimed to investigate the efficacy and safety of preemptive antiviral therapy with tenofovir disoproxil fumarate (TDF) for HBsAg-positive patients with newly diagnosed diffuse large B-cell lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy." | 8.31 | A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. ( Chang, MH; Eom, HS; Hyun, SY; Jo, JC; Kang, HJ; Kim, DY; Kim, HJ; Kim, IH; Kim, JS; Kim, MK; Kim, WS; Kim, YR; Kwak, JY; Lee, JO; Lee, WS; Lim, SN; Mun, YC; Park, Y; Shin, HJ; Suh, C; Yang, DH; Yoo, KH; Yoon, DH, 2023) |
" We evaluated the safety and efficacy of lamivudine and interferon alfa-2b with prior immunosuppression with prednisone in patients with HBeAg-positive chronic hepatitis B (CHB)." | 5.12 | [Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B]. ( Arús Soler, E; Dávila González, Y; Grá Oramas, B; Ruenes Domech, C; Vilar Gómez, E, 2006) |
"Twelve patients with a history of childhood malignancy and chronic hepatitis B were treated with prednisone for 4 weeks (0." | 5.10 | Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy. ( Benesch, M; Deutsch, J; Dornbusch, HJ; Kerbl, R; Kessler, HH; Lackner, H; Moser, A; Schwinger, W; Sovinz, P; Urban, C, 2002) |
"This prospective study aimed to investigate the efficacy and safety of preemptive antiviral therapy with tenofovir disoproxil fumarate (TDF) for HBsAg-positive patients with newly diagnosed diffuse large B-cell lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy." | 4.31 | A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. ( Chang, MH; Eom, HS; Hyun, SY; Jo, JC; Kang, HJ; Kim, DY; Kim, HJ; Kim, IH; Kim, JS; Kim, MK; Kim, WS; Kim, YR; Kwak, JY; Lee, JO; Lee, WS; Lim, SN; Mun, YC; Park, Y; Shin, HJ; Suh, C; Yang, DH; Yoo, KH; Yoon, DH, 2023) |
"We prospectively enrolled patients with negative hepatitis B surface antigen positive Anti-hepatitis B core status with or without corticosteroid use and determined corticosteroid exposure by calculating cumulative dose and time-weighted average daily dose of prednisone." | 4.12 | Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection. ( Dai, L; Feng, X; Gao, Y; Liao, W; Su, G; Wu, Q; Yang, P; Zhong, Z, 2022) |
" We aimed to explore the effectiveness and safety of low-dose prednisone or cyclosporine A (CsA) combined with nucleoside analog (NA) in patients with severe thrombocytopenia associated with HBV-related LC." | 2.80 | Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study. ( Feng, R; Fu, HX; Hu, JD; Huang, XJ; Jiang, H; Jiang, M; Jiang, Q; Liu, H; Ma, H; Niu, T; Wang, H; Wang, JW; Wang, X; Wang, Z; Wei, L; Xie, YD; Xu, LP; Zhang, XH; Zhu, XL, 2015) |
"5-3 times the upper limit of normal received prednisone for a total of six weeks prior to interferon starting at 60 mg daily with reduction in dosage by 20 mg every two weeks with a two-week period between finishing prednisone and starting interferon-alpha2b." | 2.69 | Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial. ( Hann, HW; Maddrey, WC; Martin, P; Muñoz, SJ; Rubin, R; Westerberg, S, 1998) |
"Immunoglobulin G4 (IgG4)-associated autoimmune hepatitis (AIH) was recognized as a new disease entity; however, IgG4-associated de novo AIH after the liver transplantation had not been reported yet." | 2.49 | Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review. ( Jia, JD; Rakhda, MI; Wang, TI; Zhao, XY, 2013) |
"Among these optic neuritis is a rare presentation with only a handful of cases reported in the literature thus far." | 1.48 | Recurrent optic neuritis as the only manifestation of chronic hepatitis B virus flare: a case report. ( Asif, A; Campbell, N; Curras-Martin, D; Haroon, A; Hossain, MA, 2018) |
"We report a case of autoimmune thrombocytopenia associated with acute reverse seroconversion of hepatitis B in a patient who was initially hepatitis B virus surface antigen negative and hepatitis B virus surface antibody positive." | 1.36 | Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B. ( Allegra, A; Alonci, A; D'Angelo, A; Granata, A; Musolino, C; Penna, G, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (6.67) | 18.2507 |
2000's | 11 (36.67) | 29.6817 |
2010's | 14 (46.67) | 24.3611 |
2020's | 3 (10.00) | 2.80 |
Authors | Studies |
---|---|
Zhong, Z | 1 |
Liao, W | 1 |
Dai, L | 1 |
Feng, X | 1 |
Su, G | 1 |
Gao, Y | 1 |
Wu, Q | 1 |
Yang, P | 1 |
Kim, DY | 1 |
Kim, YR | 1 |
Suh, C | 1 |
Yoon, DH | 1 |
Yang, DH | 1 |
Park, Y | 1 |
Eom, HS | 1 |
Lee, JO | 2 |
Kwak, JY | 1 |
Kang, HJ | 1 |
Hyun, SY | 1 |
Jo, JC | 1 |
Chang, MH | 1 |
Yoo, KH | 1 |
Lim, SN | 1 |
Shin, HJ | 1 |
Kim, WS | 1 |
Kim, IH | 1 |
Kim, MK | 1 |
Kim, HJ | 1 |
Lee, WS | 1 |
Mun, YC | 1 |
Kim, JS | 1 |
Park, J | 1 |
Chung, SW | 1 |
Lee, YB | 1 |
Shin, H | 1 |
Hur, MH | 1 |
Cho, H | 1 |
Park, MK | 1 |
Youk, J | 1 |
Lee, JY | 1 |
Yu, SJ | 1 |
Kim, YJ | 1 |
Yoon, JH | 1 |
Kim, TM | 1 |
Lee, JH | 2 |
Curras-Martin, D | 1 |
Campbell, N | 1 |
Haroon, A | 1 |
Hossain, MA | 1 |
Asif, A | 1 |
Zhao, XY | 1 |
Rakhda, MI | 1 |
Wang, TI | 1 |
Jia, JD | 1 |
Xuan, D | 1 |
Yu, Y | 1 |
Shao, L | 1 |
Wang, J | 1 |
Zhang, W | 1 |
Zou, H | 1 |
Garcias-Ladaria, J | 1 |
Pérez-Ferriols, A | 2 |
Ortega-García, P | 1 |
Diago, M | 1 |
Shafran, DM | 1 |
Bunce, PE | 1 |
Gold, WL | 1 |
Zhang, XH | 1 |
Feng, R | 1 |
Xu, LP | 1 |
Jiang, Q | 1 |
Jiang, H | 1 |
Fu, HX | 1 |
Liu, H | 1 |
Niu, T | 1 |
Wang, X | 1 |
Hu, JD | 1 |
Jiang, M | 1 |
Wang, Z | 1 |
Wang, JW | 1 |
Ma, H | 1 |
Xie, YD | 1 |
Zhu, XL | 1 |
Wang, H | 1 |
Wei, L | 1 |
Huang, XJ | 1 |
Ha, JM | 1 |
Sohn, W | 1 |
Cho, JY | 1 |
Pyo, JH | 1 |
Choi, K | 1 |
Sinn, DH | 1 |
Gwak, GY | 1 |
Choi, MS | 1 |
Koh, KC | 1 |
Paik, SW | 1 |
Yoo, BC | 1 |
Paik, YH | 1 |
Wei, DW | 1 |
Pagnoux, C | 1 |
Chan, CC | 1 |
Chicharro, P | 1 |
Rodríguez-Jiménez, P | 1 |
de Argila, D | 1 |
Dillon, R | 1 |
Hirschfield, GM | 1 |
Allison, ME | 1 |
Rege, KP | 1 |
Zaragoza, V | 1 |
Martínez, L | 1 |
Alegre, V | 1 |
Zeitz, J | 1 |
Mullhaupt, B | 1 |
Fruehauf, H | 1 |
Rogler, G | 1 |
Vavricka, SR | 1 |
Allegra, A | 1 |
Penna, G | 1 |
Alonci, A | 1 |
Granata, A | 1 |
D'Angelo, A | 1 |
Musolino, C | 1 |
Muñoz Bertrán, E | 1 |
Pérez Ceballos, E | 1 |
Gómez Espín, R | 1 |
Ortega González, I | 1 |
Coppola, N | 1 |
Masiello, A | 1 |
Tonziello, G | 1 |
Macera, M | 1 |
Iodice, V | 1 |
Caprio, N | 1 |
Pasquale, G | 1 |
Iavarone, M | 1 |
Perrino, M | 1 |
Viganò, M | 1 |
Beck-Peccoz, P | 1 |
Fugazzola, L | 1 |
Wijaya, I | 1 |
Sanityoso, A | 1 |
Lesmana, LA | 1 |
Lackner, H | 1 |
Moser, A | 1 |
Benesch, M | 1 |
Deutsch, J | 1 |
Kessler, HH | 1 |
Kerbl, R | 1 |
Schwinger, W | 1 |
Dornbusch, HJ | 1 |
Sovinz, P | 1 |
Urban, C | 1 |
Heathcote, J | 1 |
Vilar Gómez, E | 1 |
Grá Oramas, B | 1 |
Arús Soler, E | 1 |
Ruenes Domech, C | 1 |
Dávila González, Y | 1 |
Fernández Fernández, FJ | 1 |
de la Fuente Aguado, J | 1 |
Puerta Louro, R | 1 |
Fernández Villaverde, A | 1 |
Soto Ríos, C | 1 |
Martin, P | 1 |
Hann, HW | 1 |
Westerberg, S | 1 |
Muñoz, SJ | 1 |
Rubin, R | 1 |
Maddrey, WC | 1 |
Henrion, J | 1 |
Charton-Bain, MC | 1 |
Lelong, B | 1 |
Bouabdallah, R | 1 |
Dubus, P | 1 |
Merlio, JP | 1 |
Hassoun, J | 1 |
Xerri, L | 1 |
Suárez García, E | 1 |
Romero Gómez, M | 1 |
Grande Santamaría, L | 1 |
Matano, S | 1 |
Kobayashi, K | 1 |
Ohta, H | 1 |
Minouchi, K | 1 |
Sanada, T | 1 |
Sugimoto, T | 1 |
Tupasi, TE | 1 |
Co, VM | 1 |
Clarin, MS | 1 |
Alesna, ET | 1 |
Divinagracia, EM | 1 |
Mangubat, NV | 1 |
6 reviews available for prednisone and Hepatitis B, Chronic
Article | Year |
---|---|
Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
Topics: Antiviral Agents; Azathioprine; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; H | 2013 |
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Cohort Studies; Derm | 2014 |
[Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].
Topics: Adenine; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody | 2010 |
Treatment of HBe antigen-positive chronic hepatitis B.
Topics: Alanine Transaminase; Anti-Inflammatory Agents; Antiviral Agents; Drug Resistance; Hepatitis B e Ant | 2003 |
Treatment of chronic viral hepatitis.
Topics: Antiviral Agents; Glucocorticoids; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C | 1999 |
[Hepatic MALT lymphoma disclosing a nodal extension].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Hepatitis B, | 2000 |
5 trials available for prednisone and Hepatitis B, Chronic
Article | Year |
---|---|
Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.
Topics: Adult; Blood Coagulation Tests; China; Cyclosporine; Drug Therapy, Combination; Female; Hemorrhage; | 2015 |
Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy.
Topics: 2-Aminopurine; Adolescent; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Drug Therapy, Comb | 2002 |
[Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis B e Antigens; | 2006 |
Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Asian; DNA, Viral; Hepatitis B e Antigens; Hepatitis | 1998 |
Randomized, double-blind, placebo-controlled trial of oromucosal low-dose interferon following prednisone withdrawal for chronic hepatitis B infection in Filipino patients.
Topics: Administration, Oral; Adult; Antiviral Agents; Double-Blind Method; Drug Administration Schedule; Fe | 2002 |
19 other studies available for prednisone and Hepatitis B, Chronic
Article | Year |
---|---|
Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Hepatitis A; Hepatitis B; Hepatitis B Antibodies; Hepatit | 2022 |
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Topics: Alanine Transaminase; Antiviral Agents; Cyclophosphamide; DNA, Viral; Doxorubicin; Hepatitis B Surfa | 2023 |
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Hep | 2023 |
Recurrent optic neuritis as the only manifestation of chronic hepatitis B virus flare: a case report.
Topics: Antiviral Agents; Glucocorticoids; Guanine; Hepatitis B, Chronic; Humans; Male; Middle Aged; Optic N | 2018 |
Management of refractory telaprevir-induced dermatitis using oral corticosteroids.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Antiviral Agents; Drug Eruptions; Drug Therapy | 2014 |
Reducing the risk of infection in a 74-year-old man who is to receive prednisone.
Topics: Aged; Glucocorticoids; Hepatitis B, Chronic; Humans; Lamivudine; Latent Tuberculosis; Male; Pemphigo | 2014 |
Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic | 2015 |
Peripheral Ulcerative Keratitis Secondary to Chronic Hepatitis B Infection.
Topics: Antiviral Agents; Corneal Ulcer; Cryoglobulinemia; Cyclophosphamide; Female; Glucocorticoids; Hepati | 2017 |
Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection.
Topics: Anti-Allergic Agents; Benzimidazoles; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis | 2017 |
Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2008 |
[Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophospha | 2008 |
Hepatic failure due to hepatitis B reactivation in a patient with ulcerative colitis treated with prednisone.
Topics: Adult; Colitis, Ulcerative; Glucocorticoids; Hepatitis B, Chronic; Humans; Liver Failure, Acute; Mal | 2009 |
Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B.
Topics: Adult; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic | 2010 |
[Icteric hepatitis in a patient with non-Hodgkin's lymphoma treated by rituximab-based chemotherapy].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Ag | 2010 |
Sorafenib-induced destructive thyroiditis.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chronic Disease; Hepatitis B, C | 2010 |
Acute liver failure related to chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2012 |
[Reactivation of hepatitis B after treatment with CHOP and rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2007 |
[Current treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Anti-Inflammatory Agents; Antiviral Agents; DNA Replication; Famciclovir; Fo | 2001 |
Prophylactic effect of interferon-alpha for exacerbation of hepatitis B after high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclo | 2001 |